The market for treatments of irritable bowel syndrome (IBS) is anticipated to expand at a CAGR of 10.5% between 2023 and 2031. IBS treatment is of utmost importance in offering individuals who are afflicted with this gastrointestinal disorder, which is distinguished by symptoms such as abdominal pain, bloating, and alterations in bowel patterns, alleviation. Since 2022, the market has demonstrated ...
Read More »